Stocks · Health care · Pharmaceutical Preparations

Zentalis Pharmaceuticals, Inc.

ZNTL Clue Score26
United States Fiscal year ends December CIK 0001725160 Results filed 6 Aug 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Vincent Vultaggio
10 Feb 2026
PAO and PFO
Sold on a plan
6,894
$2.42
$16.70K
Vincent Vultaggio
9 Feb 2026
PAO and PFO
Sold on a plan
3,379
$2.39
$8.09K
Vincent Vultaggio
6 Feb 2026
PAO and PFO
Sold on a plan
29,951
$2.43
$72.77K
Vincent Vultaggio
3 Feb 2026
PAO and PFO
Sold on a plan
556
$2.52
$1.40K
Vincent Vultaggio
2 Feb 2026
PAO and PFO
Sold on a plan
2,540
$2.55
$6.48K
Vincent Vultaggio
4 Oct 2024
Principal Accounting Officer
Sold on a plan
1,603
$3.18
$5.10K
Melissa B, Epperly
4 Oct 2023
Chief Financial Officer
Sold on a plan
888
$19.91
$17.68K
Melissa B, Epperly
4 Oct 2023
Chief Financial Officer
Sold on a plan
4,594
$19.43
$89.25K
Kevin D. Bunker
4 Oct 2023
Chief Scientific Officer
Sold on a plan
983
$19.91
$19.57K
Kevin D. Bunker
4 Oct 2023
Chief Scientific Officer
Sold on a plan
5,085
$19.43
$98.78K
Carrie Brownstein
4 Oct 2023
Chief Medical Officer
Sold on a plan
1,722
$19.91
$34.29K
Carrie Brownstein
4 Oct 2023
Chief Medical Officer
Sold on a plan
8,906
$19.43
$173.01K
Jan Skvarka
11 Sep 2023
Director
Sold on a plan
5,000
$25.05
$125.24K
Cam Gallagher
31 May 2023
President
Sold on a plan
18,526
$26.21
$485.53K
Cam Gallagher
31 May 2023
President
Sold on a plan
9,242
$26.40
$243.98K
Kevin D. Bunker
26 May 2023
Chief Scientific Officer
Sold on a plan indirect
80,000
$30.02
$2.40M
Showing 250 of 464 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 221
Amendments (4/A) skipped 3
Filings about a different issuer 0
Unreadable filings 0
Joint filings 6
Sales on a Rule 10b5-1 plan 16
Sales straight out of an exercise 17
Sales at will 414
Transactions with no price 0
Shares from compensation/vesting 12,076,610
Sales filed before the plan box existed 397
History held since 8 Apr 2020